Skip to main content
. 2015 Jun 1;6(7):658–670. doi: 10.7150/jca.11647

Figure 9.

Figure 9

Anti-tumor capability assessment (24 h). (A)The inhibition ratio of HepG2 cells incubated with different concentration of DOX and Gal-DOX. (B)The inhibition ratio of HepG2, MCF-7 and L02 cells incubated with DOX and Gal-DOX (DOX and Gal-DOX were adjusted to have the same amount of DOX as 10 μg/mL).